Intervene stocks
Therapies and devices that create demand for the healthspan toll-road stack.
H6 capability map
Intervene technologies
Open a technology to understand the capability, evidence framework and every directly mapped public stock.
Research coming soon
Cystic Fibrosis, Cell Therapy, Casgevy
1 stock mapped · Open research ↗ Research coming soonDurable Therapeutic Platforms
1 stock mapped · Open research ↗ Research coming soonGene Therapy, Radioligand
1 stock mapped · Open research ↗ Research coming soonGLP-1 Demand Engine
7 stocks mapped · Open research ↗ Research coming soonImmunology Inflammation and Rare Disease
3 stocks mapped · Open research ↗ Research coming soonInterventional Devices
1 stock mapped · Open research ↗ Research coming soonMariTide Monthly Injectable
1 stock mapped · Open research ↗ Full researchMedical Imaging Systems
1 stock mapped · Open research ↗ Research coming soonOrthopedic Implants & Digital Surgery
2 stocks mapped · Open research ↗ Research coming soonSemaglutide, CagriSema
1 stock mapped · Open research ↗ Full researchStructural Heart & Transcatheter Valves
4 stocks mapped · Open research ↗ Research coming soonSurgical Robotics
3 stocks mapped · Open research ↗ Research coming soonTirzepatide, Foundayo, Retatrutide
1 stock mapped · Open research ↗ Research coming soonVK2735 dual agonist
1 stock mapped · Open research ↗Intervene stock picks
MDTMedtronicStructural heart, cardiac surgery
Intervene
WATCH●●○○○
●●○○○
$96.66Research target
8/23/26Last reviewed
↗
GEHCGE HealthCareImaging systems
Intervene
WATCH●●○○○
●●○○○
$84.19Research target
8/16/26Last reviewed
↗
VKTXViking TherapeuticsVK2735 dual agonist
Intervene
WATCH●●○○○
●●○○○
$71.19Research target
8/16/26Last reviewed
↗
ABBVAbbVieImmunology, oncology, neuroscience
Intervene
WATCH●●○○○
●●○○○
$227.27Research target
7/31/26Last reviewed
↗
AMGNAmgenMariTide monthly injectable
Intervene
WATCH●●○○○
●●○○○
$340.84Research target
7/31/26Last reviewed
↗
BSXBoston ScientificInterventional devices
Intervene
WATCH●●○○○
●●○○○
$80.96Research target
7/31/26Last reviewed
↗
EWEdwards LifesciencesStructural heart, TAVR
Intervene
WATCH●●○○○
●●○○○
$90.50Research target
7/31/26Last reviewed
↗
LLYEli LillyTirzepatide, Foundayo, retatrutide
Intervene
WATCH●●○○○
●●○○○
$870Research target
7/31/26Last reviewed
↗
MRKMerckOncology, vaccines, immunology
Intervene
WATCH●●○○○
●●○○○
$135Research target
7/31/26Last reviewed
↗
NVONovo NordiskSemaglutide, CagriSema
Intervene
WATCH●●○○○
●●○○○
$109.07Research target
7/31/26Last reviewed
↗
NVSNovartisGene therapy, radioligand
Intervene
WATCH●●○○○
●●○○○
$115.94Research target
7/31/26Last reviewed
↗
REGNRegeneronDurable therapeutic platforms
Intervene
WATCH●●○○○
●●○○○
$878.34Research target
7/31/26Last reviewed
↗
SYKStrykerOrthopedics, Mako robotics
Intervene
WATCH●●○○○
●●○○○
$363.89Research target
7/31/26Last reviewed
↗
VRTXVertex PharmaceuticalsCystic fibrosis, cell therapy, Casgevy
Intervene
WATCH●●○○○
●●○○○
$460.47Research target
7/31/26Last reviewed
↗
ZBHZimmer BiometOrthopedics, implants
Intervene
WATCH●●○○○
●●○○○
$122.02Research target
7/31/26Last reviewed
↗
No stock picks match these filters.